Tom Chi
Founder & Partner @ At One Ventures
San Francisco, United States
Tom Chi is a Series A investor at At One Ventures in San Francisco focused on Biotechnology and Solar. Tom Chi is based out of San Francisco, California and is the Board of Director of Provectus Algae. Tom also serve as Founding Partner of At One Ventures. Tom Chi attended Cornell University.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 48%
Last updated:
For AI agents: llms.txt
Industries Tom Chi invests in
Stages Tom Chi invests in
Countries Tom Chi invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.1M–$10M
- Series A
- $2.8M–$60M
- Series B
- $30M–$34M
Investment Focus
Industry
- Biotechnology 3 (13%)
- Solar 2 (9%)
- Analytics 2 (9%)
- Industrial 2 (9%)
- Agriculture 2 (9%)
Stage
- Series A 9 (39%)
- Seed 8 (35%)
- Series B 2 (9%)
- Venture - Series Unknown 1 (4%)
Country
- United States 11 (48%)
- Canada 2 (9%)
- United Kingdom 2 (9%)
- Denmark 1 (4%)
- Australia 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Blue Energy is a nuclear power plant company that provides reliable, clean, and abundant electricity. | $380M / Venture - Series Unknown / Apr 21, 2026 | ||
| Miraterra's solution produces lab-quality findings in soil labs, the field, and the ground. Miraterra's accurate measurements, advanced reporting, and verification technologies will enable a new era of precision agriculture and carbon market credibility. | $11.6M / Seed / Mar 25, 2026 | ||
| MightyFly is enabling worldwide access to goods with fast, on-demand delivery services for businesses and consumers. We’re putting the infrastructure in place to connect remote locations together with long range, heavy cargo aircraft. Many areas in the world today suffer from an inability to obtain critical and often urgently needed goods andsupplies at an affordable cost. Our goal at MightyFly is to solve this problem through express, customized aerial drone delivery services. MightyFly drones will transport cargo to multiple locations in a single flight across hundreds of miles of remote terrain that is difficult if not impossible to cross with trucks or other ground vehicles. We are developing vertical-takeoff-and-landing (VTOL) drones that fly more than 300 miles, and carry payloads in excess of 50 pounds at a fraction of the cost of helicopters. Featuring automated cargo loading and unloading, and requiring no launch or recovery infrastructure, MightyFly drones will accommodate ad-hoc deliveries to undeveloped sites as well as servicing locations along established routes. | $10M / Seed / Feb 12, 2026 | ||
| Provectus Algae is a biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technologyand a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners.Microalgae biotechnology holds tremendous potential for countless industries and products, thanks to microalgae’s impressive biochemical diversity, sophisticated biosynthesis machinery, and rapid growth rates, among other functional attributes. Importantly, photosynthetic microalgae species can also turn CO2 into valuable and in-demand biomolecules, providing the life science community with a powerful mechanism for adopting more sustainable biomanufacturing processes and reducing carbon footprint.Provectus Algae has built an end-to-end biomanufacturing platform capable of taking microalgae-based products from discovery to large-scale production, actualizing the full potential of microalgae biotechnology. We have brought together the combined strengths of our talented multidisciplinary team to rapidly build scalable microalgae production systems and source high-value compounds for our partners in the food and beverage, cosmetic, therapeutic, and agricultural industries. | $10.1M / Series A / Jul 22, 2025 | ||
| Blue Energy is a nuclear power plant company that provides reliable, clean, and abundant electricity. | $45M / Series A / Oct 08, 2024 | ||
| Dalan Animal Health is a vaccine platform with the potential to combat a variety of devastating bee diseases. The company was founded in 2018 and is headquartered in Athens, Georgia, United States. | $4.5M / Seed / Jun 27, 2023 | ||
| EnrichAg will focus on commercializing its soil enrichment platform. | $6M / Seed / Jan 12, 2023 | ||
| Cruz Foam develops structural foams intended to help end the global issue of plastic pollution from oceans. It produces bio-benign foam and eco-friendly EPS-alternative solutions that powers key industry leaders to be the catalyst for a cleaner environment. The company's products are produced from naturally sourced biopolymers that create ascalable, compostable alternative using the existing supply chain and at a similar cost. Current industry partners include consumer electronics, appliances, shipping, and consumer packaged goods. Cruz Foam was founded in 2017 and is headquartered in Santa Cruz, California. | $18M / Series A / Oct 28, 2022 | ||
| Halo. Car is to hasten the world's switch to electric cars by providing incredibly convenient electric car sharing. | $5M / Seed / Oct 04, 2022 | ||
| Colossal is a ground-breaking bioscience and gene engineering firm that develops cutting-edge genomics technology. | $60M / Series A / Mar 09, 2022 | ||
| See all 23 investments → | |||
Co-Investors
About At One Ventures
At One Ventures finds, funds, and grows teams to catalyze a world where humanity is a net positive to nature.They back early-stage (Seed, Series A) companies that are using disruptive deep tech to upend the unit economics of established industries while dramatically reducing their planetary footprint. They also look for companies that arepioneering new industries that are actively regenerative to planetary health. Lastly, they look for companies that have significant potential to be healthy, scalable businesses, because the positive impacts they invest in only last as long as the businesses that carry them.
At One Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Laurie Menoud
Partner
|
|||
|
Tom Chi
Founder & Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Tom Chi invest in?
Tom Chi invests primarily in Biotechnology, Solar and Analytics startups, most often at Series A and Seed stage. Most of the 23 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Tom Chi's check size?
Tom Chi typically joins rounds of $1.1M–$10M at Seed, $2.8M–$60M at Series A and $30M–$34M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Tom Chi participates in.
How do I contact Tom Chi?
Public channels for Tom Chi include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Tom Chi last invest?
The most recent investment recorded for Tom Chi closed in Apr 2026. Shizune tracks 23 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
